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Introduction {#sec001}
============

Back pain is the leading cause for global disability and the most common reason for doctor visits \[[@pone.0227527.ref001]\]. Obesity is among the strongest risk factors for back pain \[[@pone.0227527.ref002],[@pone.0227527.ref003]\] and in the United States, obesity is rising among children and adolescents with a prevalence of 21% among those 12--19 years old \[[@pone.0227527.ref004]\]. Children who are obese are at significantly higher risk of health problems and the most common co-morbidity associated with obesity is type 2 diabetes \[[@pone.0227527.ref001]\].

The susceptibility to skeletal fractures is increased in obese and diabetic children and adults \[[@pone.0227527.ref005]--[@pone.0227527.ref007]\]. However, little is known about the characteristics of bone structure in early life and how diabetes affects the bone modeling and remodeling. Bone mineral density of diabetic patients can be lower, normal, or even greater compared to age-matched non-diabetic controls \[[@pone.0227527.ref008]--[@pone.0227527.ref010]\], suggesting that increased fracture risk in diabetic patients is likely associated with alterations in bone microstructure and material properties rather than bone mineral density alone. Body fat mass has sex dependent effects on vertebral and femoral bone quality of juveniles, demonstrated by an association of body fat mass with decreased bone stiffness \[[@pone.0227527.ref011],[@pone.0227527.ref012]\]. Moreover, the prevalence of obesity and fracture risk are higher in diabetic women than men \[[@pone.0227527.ref013]--[@pone.0227527.ref015]\]. The literature on sex-dependent bone changes highlights a need to identify the sex effects of obesity and diabetes on vertebral pathologies in the development of spinal pathologies.

Recent literature also suggest that women are more susceptible to IVD disorders than men \[[@pone.0227527.ref016]\] and while the sex-dependent effect of diabetes on IVD degeneration is not known, several clinical studies demonstrated that the incidence of IDD is higher in obese and diabetic individuals \[[@pone.0227527.ref017]--[@pone.0227527.ref021]\].

Yet, the evidence for a link between these conditions remains inconsistent and some studies did not identify an association between obesity, diabetes and IVD degeneration \[[@pone.0227527.ref022]--[@pone.0227527.ref025]\]. The hypothesis that diabetes contributes to IVD degeneration is supported mostly by animal experiments, which demonstrate diabetes as a contributor to IVD degeneration \[[@pone.0227527.ref025]\]. In UCD-T2DM rats, diabetes and obesity together caused significantly decreased IVD creep strain and increased IVD stiffness, which was not observed in obese, non-diabetic control rats \[[@pone.0227527.ref026]\]. In mice with type 1 diabetes, we previously demonstrated decreased glycosaminoglycan content, structural deterioration in IVDs and decreased bone mass in vertebrae \[[@pone.0227527.ref027]\]. The literature highlights a need to identify a more mechanistic understanding of the contribution of obesity and diabetes on IVD and vertebral dysfunction in the development of spinal pathologies.

Obesity is characterized by hyperleptinemia due to the development of leptin resistance \[[@pone.0227527.ref028]\]. Leptin is a cytokine-like hormone that primarily regulates appetite, is increased with obesity, and significantly higher expressed in obese women than in obese men \[[@pone.0227527.ref029]\]. Mice with leptin receptor deficiency exhibit polyphagia, resulting in severe obesity, elevated blood glucose, diabetes, and increased vertebral bone mass \[[@pone.0227527.ref030]--[@pone.0227527.ref032]\]. Db/Db mice develop obesity and diabetes early in life, making it a suitable model to mimic the effects of diabetes in children and juveniles. In addition to its role in appetite regulation, leptin and its receptors have been associated with human IVD degeneration \[[@pone.0227527.ref033],[@pone.0227527.ref034]\]; and *in vitro* studies have demonstrated pro-catabolic and proinflammatory effects of leptin on nucleus pulposus (NP) and annulus fibrosus (AF) cells \[[@pone.0227527.ref035]--[@pone.0227527.ref037]\].

This study utilized the Db/Db genotype as well as the Western diet to enhance obesity and diabetes due to impaired leptin signaling. We hypothesized that leptin receptor deficient Db/Db mice would exhibit altered vertebral structure, IVD morphology, and spinal mechanical behavior, particularly in female mice.

Methods {#sec002}
=======

Mouse model and experiment design {#sec003}
---------------------------------

All animal experiments were performed according to the IACUC protocol at the Icahn School of Medicine at Mount Sinai, New York, NY. To investigate the effects of diet, sex and obesity-associated diabetes on spine, leptin receptor-deficient mice on a C57BL/6J background (B6.BKS(D)-Lepr^db^/J (Db/Db) (15 females, 19 males) mice and their heterozygoes (Control) littermates (21 females, 27 males) mice were used ([Fig 1A](#pone.0227527.g001){ref-type="fig"}). We chose Db/Db mice on a C57BL/6J background because this mouse strain becomes identifiably obese around 3 to 4 weeks of age, becomes polyphagic, polydipsic, and polyuric and have compensatory hyperplasia of the islet B cells, resulting in a mild diabetic phenotype. \[[@pone.0227527.ref038]\] After weaning, both Db/Db and Control mice were assigned to receive either Western diet (WD) or Western control diet (CD). The WD diet was formulated to mimic a "Western fast-food diet" with about 40% kcal from fat and 45% from carbohydrates (5TJN - Western Diet for Rodents, TestDiet, St. Louis, MO, USA); while the CD diet was a low-fat control for the Western diet with about 10% kcal from fat and 72% from carbohydrates (5TJS - Low Fat Control for Western Diets, TestDiet; [Fig 1B](#pone.0227527.g001){ref-type="fig"}). Mice were group housed with ad libitum access to water and assigned diet as well as unrestricted cage activities. At 12 weeks of age, the mice were anesthetized by Ketamine-Xylazine injection (Forane, Baxter, IL, USA), body weights were measured, and mice were euthanized by cardiac puncture. After sacrifice, blood was collected for fasting blood glucose and hemoglobin A1c (HbA1c) levels. Lumbar spines were collected for structural, biochemical analysis. Coccygeal spines were used for biomechanical analyses ([Fig 1A](#pone.0227527.g001){ref-type="fig"}).

![Study design.\
A) Leptin receptor deficient mice and their heterozygous controls were fed either a Western Diet or Control Diet diet. Mice were sacrificed at 12 weeks. B) Dietary information.](pone.0227527.g001){#pone.0227527.g001}

Blood glucose and HbA1c {#sec004}
-----------------------

Fasting blood glucose and HbA1c levels were used to determine the diabetic status of the mice. After 6 hours of fasting, blood glucose was analyzed using an Aimstrip Plus Glucose Meter (Germaine Laboratories, San Antonio, TX, USA). For the measurement of HbA1c levels, the collected blood was stored in EDTA coated tubes at -80°C until further analysis. HbA1c levels were assessed using an enzymatic assay kit (Mouse Hemoglobin A1c Assay Kit \#80310, Crystal Chem, Elk Grove Village, IL, USA) according to manufacturer's instructions.

MicroCT assessment of vertebral morphology {#sec005}
------------------------------------------

Lumbar spines (L3-5) were dissected and stored in 10% buffered formalin phosphate fixative prior to μCT scanning. L4 vertebraes were scanned at 77--78 kV × 80 μA power with a resolution of 4.9--5.0 μm/pixel, an X-ray exposure time of 1767 ms (SkyScan 1172; Bruker Corp., Kontich, Belgium). Samples were kept hydrated in PBS while scanned in air. Hydroxyapatite phantoms (0.25 and 0.75 mg/cm^3^) were also scanned for mineral density calibration. μCT projections were reconstructed (N-Recon, V1.01; Bruker), and digitally aligned for consistent measurements between samples (Dataviewer V1.01; Bruker). A 1 mm region of interest was analyzed and selected to exclude growth plates based on a 0.5 mm offset from a landmark that consisted of approximately 50% of the caudal growth plate. A sole experimenter conducted all analyses to prevent bias selection of landmarks. Trabecular and cortical bone parameters were assessed following separation of bone compartments using a custom task list created in the custom processing tab of CTAn. Trabecular bone parameters assessed by 3D analysis for trabecular bone volume fraction, trabecular thickness, trabecular number, and trabecular spacing. Cortical bone parameters were assessed by 2D analysis for cortical area fraction, cross-sectional thickness, cortical area, and total area. Bone mineral density and tissue mineral density parameters were also calculated in CTAn under the Binary Image tab, keeping the threshold value consistent for all samples.

IVD height index (DHI) {#sec006}
----------------------

Mid-sagittal μCT images of the mice lumbar spine were used to manually identify the boundaries of the L4-5 IVD and the L4 vertebra using ImageJ. Coordinates were then used to determine IVD height and vertebral length using a customized MATLAB script (Mathworks, Inc., Natick, MA). To exclude the effects of body size between groups mice, an index was used to compare IVD heights: DHI = (DH1 + DH2 + DH3)/(A1 + A2 + A3), where A represents the length of the L4 vertebral bone immediately caudal to the L4-5 IVD, and DH represents the IVD height of the adjacent IVD (modified from \[[@pone.0227527.ref039]\]).

IVD morphology {#sec007}
--------------

Immediately after euthanization, L1-3 motion segments were isolated, and fixed in 10% buffered formalin. IVD-vertebrae segments were decalcified then embedded in paraffin, and sectioned sagittally at 5μm intervals for histological analysis. Mid-sagittal sections were stained with Picrosirius Red-Alcian Blue staining (PRAB) for collagen and proteoglycans, and imaged under bright field microscopy with standardized exposure time. The severity of IVD degeneration was quantified using a semi-quantitative grading system within 5 parameters for signs of degeneration, including NP structure, NP clefts/fissures, AF structure, AF clefts/fissures, and NP/AF boundary \[[@pone.0227527.ref040]\]. All sections were examined by two researchers blinded to the experimental groups, and then averaged for analysis \[[@pone.0227527.ref041]\]. The boundaries of notochordal band and NP were manually defined in photoshop, and the area of notochordal band relative to area of NP was calculated by outlining both notochordal band and total NP area in photoshop. IVD cellularity was visualized using hematoxylin staining with eosin as counter-staining \[[@pone.0227527.ref042]\], and then imaged under bright field microscopy with standardized exposure time. IVD cells within the notochordal band were manually counted using ImageJ, and then normalized to the area counted.

Motion segment biomechanics {#sec008}
---------------------------

Biomechanical properties of caudal vertebra-IVD-vertebra motion segment (Co4-5) were assessed via tension-compression, creep, and torsional tests; which provide substantial information to evaluate properties of NP pressurization and hydration, AF lamellae integrity and quality, as well as IVD laxity and viscoelasticity. Immediately after dissection, Co4-5 motion segments were wrapped in phosphate buffer saline (PBS)-soaked paper towels and stored at −80°C until the day of testing. Axial and creep tests were performed using the ElectroForce 3200 testing machine (Bose Corporation, Eden Prairie, MN), and torsional tests were performed using the AR2000x Rheometer (TA Instruments, New Castle, DE, USA).

The testing protocol was adopted from our previous studies \[[@pone.0227527.ref043]--[@pone.0227527.ref045]\]. In brief, on the day of testing, after 10 mins in PBS for thawing and hydrating, the motion segment specimens were loaded into parallel-platens of an axial loading machine (Bose ElectroForce 3220; TA Instruments, New Castle, DE, USA) using a custom-designed fixture with a fluid bath of PBS for axial testing. During the axial testing, specimens underwent 20 cycles of ±0.5 N tension-compression test at 1 Hz, followed by 1 min of dwelling to allow the specimens to relax, and then 45 mins of creep test with the compressive force at 0.5 N. After 30 min of rehydration in PBS, specimens were attached to a rheometer (AR2000; TA Instruments, New Castle, DE, USA) using a custom-designed fixture for torsional testing which consisted of 20 cycles of ±10° rotation in both directions at 1 Hz, followed by torsion-to-failure test at the rate of 1°/s. The loading profile obtained from the 20th cycle of tension-compression and torsional tests were used to determine compressive stiffness, tensile stiffness, axial range of motion, axial neutral zone length, torsional stiffness (average from the stiffness obtained from clockwise and counterclockwise direction), torsional neutral zone length and torque range using custom-written MATLAB codes. For analyzing the characteristics of creep test, a 5-parameter viscoelastic solid model was applied to calculate creep and total displacements, elastic stiffness, time constant (*τ*) and stiffness for both fast response and slow response using a custom-written MATLAB code as previously described \[[@pone.0227527.ref043],[@pone.0227527.ref046]\]. For the torsion-to-failure test, the failure strength and angle to failure were identified manually from the loading profile.

Statistical analyses {#sec009}
--------------------

Body weight, blood glucose level, HbA1c, vertebral morphology, DHI, motion segment biomechanics, and IVD score were compared using two-way ANOVA to assess the effects of genotype and diet. Tukey's post-hoc comparison was performed to assess the effects of Western diet and Db/Db genotype on vertebral and IVD changes. Results were analyzed for females and males separately and displayed as average ± standard deviation. All statistical analyses were performed using Graphpad Prism7 (GraphPad Software, Inc., La Jolla, CA) with level of significance set at 0.05.

Results {#sec010}
=======

General observations confirmed an obese and pre-diabetic phenotype {#sec011}
------------------------------------------------------------------

As expected, at 3 months, Db/Db genotype and WD caused significantly increased body weight compared to control mice on CD and Db/Db mice on WD ([Table 1](#pone.0227527.t001){ref-type="table"} and [Fig 2](#pone.0227527.g002){ref-type="fig"}). Db/Db genotype caused significantly increased HbA1c levels and was highest in female Db/Db WD mice ([Table 1](#pone.0227527.t001){ref-type="table"} and [Fig 3](#pone.0227527.g003){ref-type="fig"}). Only Female Db/Db mice on WD developed diabetes (\<150 mg/dL \[[@pone.0227527.ref047]\]), which was significantly increased at 4 weeks. ([Table 1](#pone.0227527.t001){ref-type="table"} and [Fig 3](#pone.0227527.g003){ref-type="fig"}). Male mice were pre-diabetic with significantly increased blood glycose levels in Db/Db mice on WD compared to control mice at 4 & 8 weeks ([Table 1](#pone.0227527.t001){ref-type="table"} and [Fig 3](#pone.0227527.g003){ref-type="fig"}). Overall, HbA1c results indicate that all Db/Db mice were pre-diabetic and female Db/Db WD mice were diabetic \[[@pone.0227527.ref048],[@pone.0227527.ref049]\].

![Leptin receptor deficiency and Western diet both increased fasting body weight in mice, for both male and female groups.\
p \< 0.5. wk = weeks.](pone.0227527.g002){#pone.0227527.g002}

![Leptin receptor deficiency increased HbA1c in mice for both male and female groups.\
A) HbA1c was elevated to diabetic levels in female mice. B) Blood glucose did not reach diabetic levels. p \< 0.5. wk = weeks.](pone.0227527.g003){#pone.0227527.g003}

10.1371/journal.pone.0227527.t001

###### General observations.

![](pone.0227527.t001){#pone.0227527.t001g}

                  Female         Male     CD versus WD (*p*)                                                                                                                                                                 
  --------------- -------------- -------- -------------------- -------- -------- ------------- ------------- -------- ------------- --------- -------- ------------- ------------- ------------- ------------- ------------- -----------
  Body Weight     4 wk (g)       14.89    17.35                0.421    16.00    22.51         **\<0.001**   14.91    14.77         \>0.999   19.08    20.48         0.733         0.783         **0.012**     **0.010**     **0.001**
  ±2.25           ±2.49          ±2.88    ±2.46                ±3.59    ±2.42    ±2.47         ±3.76                                                                                                                         
  8 wk (g)        19.74          31.04    **\<0.001**          24.44    41.56    **\<0.001**   24.24         30.07    **\<0.001**   32.98     43.71    **\<0.001**   **0.004**     **\<0.001**   **\<0.001**   **\<0.001**   
  ±1.22           ±4.29          ±2.67    ±3.44                ±3.34    ±2.34    ±3.52         ±2.76                                                                                                                         
  12 wk (g)       22.84          39.36    **\<0.001**          30.28    49.20    **\<0.001**   27.28         40.21    **\<0.001**   37.60     54.11    **\<0.001**   **\<0.001**   **\<0.001**   **\<0.001**   **\<0.001**   
  ±1.71           ±3.56          ±3.19    ±5.65                ±3.66    ±2.82    ±3.28         ±2.84                                                                                                                         
  Blood Glucose   4 wk (mg/dL)   114.72   122.50               0.996    122.15   218.30        **0.031**     131.00   106.40        0.488     141.21   154.30        0.874         0.982         **0.001**     0.926         **0.044**
  ±28.33          ±31.14         ±29.44   ±65.19               ±41.97   ±35.60   ±40.91        ±47.73                                                                                                                        
  8 wk (mg/dL)    118.56         187.50   0.091                122.12   159.65   0.417         130.56        92.68    0.078         141.50    141.30   \>0.999       0.999         0.764         0.890         **0.034**     
  ±34.49          ±87.03         ±26.64   ±80.30               ±29.18   ±12.32   ±34.39        ±62.08                                                                                                                        
  12 wk (mg/dL)   108.22         170.64   0.148                113.39   172.89   **0.017**     131.47        122.18   0.938         141.29    141.33   \>0.999       0.997         0.954         0.923         0.718         
  ±30.31          ±49.52         ±26.24   ±80.81               ±36.33   ±35.39   ±54.22        ±20.58                                                                                                                        
  HbA1c (%)       4.84           6.23     0.474                5.15     7.49     **0.031**     5.29          5.69     0.312         5.13      6.09     **0.002**     0.982         0.527         0.866         0.428         
  ±0.38           ±2.16          ±0.34    ±3.10                ±0.55    ±0.57    ±0.46         ±0.63                                                                                                                         

Western diet and Db/Db genotype had sex-dependent effects on vertebral bone microstructure {#sec012}
------------------------------------------------------------------------------------------

Trabecular bone structure was strongly affected by Db/Db genotype. Two-way ANOVA demonstrated a genotype effect on trabecular bone structure and subsequent post-hoc testing revealed that both female and male Db/Db mice had increased trabecular bone volume fraction with increased trabecular number and decreased trabecular spacing, which was independent from diet ([Fig 4](#pone.0227527.g004){ref-type="fig"} and [Table 1](#pone.0227527.t001){ref-type="table"}). In female mice, 2-way ANOVA testing demonstrated a strong genotype effect on cortical bone volume fraction, cortical thickness, cortical area, and cortical bone surface to volume ratio, which, after post-hoc testing, remained significant for Db/Db mice on WD. In male mice, 2-way ANOVA revealed that a genotype effect was only observed for cortical thickness and cortical bone surface to volume ratio, while diet affected the cortical area. However, after post-hoc testing, only cortical bone surface to volume changes were independent from diet, while no differences were observed in male mice for any other parameters; suggesting that dietary effects on bone structure in Db/Db mice were sex-dependent ([Fig 5](#pone.0227527.g005){ref-type="fig"} and [Table 2](#pone.0227527.t002){ref-type="table"}).

![Trabecular bone increased with leptin receptor deficiency.\
A) 3D μCT images of trabecular bone of (top) female and (bottom) male mice. B) BV/TV C) Tb.Sp, and D) Tb.N demonstrate inferior Tb microstructure with Db/Db genotype. Only female Db/Db mice had E) increased Tb. BMD and F) decreased Tb.Th. p \< 0.05. BV/TV = bone volume fraction; Tb.Sp = trabecular spacing; Tb.N--trabecular number; Tb. BMD = trabecular bone mineral density; Tb.Th = trabecular thickness.](pone.0227527.g004){#pone.0227527.g004}

![Leptin receptor deficiency caused decrease in cortical bone mainly in female mice.\
A) 3D μCT images of cortical bone for (top) female and (bottom) male mice. Two-way ANOVA revealed that, in female mice, leptin receptor deficiency decreased B) Ct.Ar/Tt.Ar C) Ct.Ar and D) Ct.Th. While increasing G) Ct.BS/BV. Post Hoc testing indicated that this effect was only significant in female mice on WD. No changes were observed for E) Tt.Ar or F) Ct.TMD. In male 2-way ANOVA analysis indicated a diet effect in Ct.Ar and a genotype effect in Ct.Th and Ct. BS/BV. Post Hoc testing indicated that increased Ct.BS/BV was only significant in male mice on WD p \< 0.05. Ct.Ar/Tt.A*r* = cortical area fraction; Ct.Ar = cortical area; Ct.Th = cortical thickness; Tt.Ar = total area; Ct. TMD cortical tissue mineral density.](pone.0227527.g005){#pone.0227527.g005}

10.1371/journal.pone.0227527.t002

###### uCT parameters.

![](pone.0227527.t002){#pone.0227527.t002g}

                       Female          Male      CD versus WD (*p*)                                                                                                                                                         
  -------------------- --------------- --------- -------------------- ------------ -------- ------------- ----------- -------- ------------- ----------- -------- ------------- ----------- ----------- --------- --------- -------
  Trabecular           Tb. BV/TV (%)   19.650    26.663               **0.0001**   21.516   24.105        0.151       20.852   26.004        **0.003**   20.773   25.152        **0.011**   0.469       0.223     \>0.999   0.991
  ±1.991               ±2.603          ±2.220    ±3.241               ±1.841       ±1.590   ±2.324        ±4.349                                                                                                            
  Tb.Sp (mm)           0.187           0.148     **\<0.001**          0.180        0.142    **\<0.001**   0.153       0.134    **\<0.001**   0.151       0.137    **0.002**     0.643       0.814       0.954     0.867     
  ±0.018               ±0.010          ±0.012    ±0.010               ±0.007       ±0.003   ±0.009        ±0.009                                                                                                            
  Tb.N (1/mm)          3.951           5.215     **\<0.001**          4.189        5.210    **\<0.001**   4.594       5.387    **0.001**     4.574       5.403    **\<0.001**   0.641       \>0.999     \>0.999   \>0.999   
  ±0.412               ±0.344          ±0.3603   ±0.489               ±0.185       ±0.168   ±0.458        ±0.548                                                                                                            
  Tb.BMD (mg/cm3)      0.313           0.396     **0.0003**           0.323        0.351    0.443         0.335       0.390    0.058         0.324       0.373    0.099         0.949       0.132       0.132     0.848     
  ±0.033               ±0.030          ±0.043    ±0.047               ±0.034       ±0.033   ±0.036        ±0.062                                                                                                            
  Tb.Th (mm)           0.050           0.051     0.858                0.051        0.046    **0.012**     0.045       0.048    0.327         0.045       0.046    0.953         0.779       **0.029**   \>0.999   0.653     
  ±0.002               ±0.005          ±0.001    ±0.001               ±0.003       ±0.003   ±0.003        ±0.004                                                                                                            
  Tb. BS/BV (mm^-1^)   69.530          66.020    0.625                68.110       75.480   **0.030**     75.800      70.250   0.458         76.930      75.540   0.981         0.951       **0.009**   0.989     0.498     
  ±2.59                ±7.41           ±4.38     ±6.26                ±5.82        ±5.51    ±6.08         ±11.44                                                                                                            
  Cortical             Ct.Ar/Tt.Ar     0.210     0.202                0.880        0.224    0.186         **0.003**   0.198    0.194         0.947       0.201    0.196         0.994       0.528       0.499     0.959     0.994
  ±0.019               ±0.021          ±0.015    ±0.027               ±0.019       ±0.006   ±0.012        ±0.014                                                                                                            
  Ct.Ar (mm^2^)        1.470           1.463     0.892                1.564        1.453    **\<0.001**   1.606       1.516    0.787         1.680       1.654    0.189         0.074       0.449       0.507     0.390     
  ±0.075               ±0.066          ±0.144    ±0.093               ±0.086       ±0.126   ±0.118        ±0.104                                                                                                            
  Ct.Th (mm)           0.063           0.058     0.312                0.069        0.054    **\<0.001**   0.061       0.057    0.203         0.063       0.059    0.698         0.144       0.394       0.693     0.216     
  ±0.006               ±0.005          ±0.005    ±0.006               ±0.005       ±0.002   ±0.004        ±0.005                                                                                                            
  Tt.Ar (mm^2^)        1.47            1.56      0.999                1.46         1.45     0.115         1.61        1.68     0.337         1.516       1.654    0.961         0.278       0.997       0.492     0.062     
  ±0.08                ±0.07           ±0.14     ±0.09                ±0.09        ±0.13    ±0.12         ±0.10                                                                                                             
  Ct.TMD (mg/cm3)      1.141           1.117     0.629                1.094        1.022    0.111         1.121       1.096    0.895         1.094       1.056    0.743         0.938       0.23        0.927     0.764     
  ±0.060               ±0.027          ±0.114    ±0.075               ±36.33       ±35.39   ±54.22        ±20.58                                                                                                            
  Ct.BS/BV (mm^1^)     41.5            46.17     0.167                38.53        50.14    **\<0.001**   42.65       46.87    **0.037**     41.32       45.25    **0.049**     0.468       0.243       0.794     0.697     
                       ±3.23           3.97      ±2.74                ±5.73        ±3.17    ±1.83         ±2.32       ±4.21                                                                                                 

Db/Db genotype caused sex dependent changes in IVD morphology, but did not induce IVD degeneration {#sec013}
--------------------------------------------------------------------------------------------------

Pronounced differences in IVD morphology were observed between female Control and Db/Db mice ([Fig 6](#pone.0227527.g006){ref-type="fig"}). IVDs of female Db/Db mice had a significantly increased notochordal band area with large, vacuolated cells, and significantly fewer cells per area compared to female control mice. These changes were independent from diet. Despite these pronounced differences in morphology, leptin receptor deficiency did not cause IVD degeneration in 3 months old mice ([Table 3](#pone.0227527.t003){ref-type="table"}). There was no difference in Tam IVD grading score between any groups. No effects of diet or genotype on IVD structure or morphology were detected in male mice ([Table 3](#pone.0227527.t003){ref-type="table"}). No differences in DHI were observed for any group, although some significant but subtle alterations in vertebral length and IVD height were identified ([Table 4](#pone.0227527.t004){ref-type="table"} and [Fig 7](#pone.0227527.g007){ref-type="fig"}).

![Notochordal band size increased in female leptin receptor deficient mice.\
A) Representative Picrosirius red/Alcian blue images demonstrate an increased notochordal band in (top) female Db/Db mice. B) Db/Db genotype did not cause IVD degeneration. In female Db/Db mice, C) notochordal cell size was increased and D) cells per area was decreased. No changes were observed in male IVDs. Black boxes mark region of interest (ROI).](pone.0227527.g006){#pone.0227527.g006}

![Leptin receptor deficiency caused decrease vertebral length and disc height, but no change in disc height index.\
A) Schematic of IVD height and vertebrae length measurement. B) μCT midsagittal sections of vertebral bone for (top) female and (bottom) male. p \< 0.05. C) vertebral length D) IVD height E) DHI.](pone.0227527.g007){#pone.0227527.g007}

10.1371/journal.pone.0227527.t003

###### IVD morphology.

![](pone.0227527.t003){#pone.0227527.t003g}

                       Female   Male     CD versus WD (*p*)                                                                                                          
  -------------------- -------- -------- -------------------- ------- ------- ----------- -------- ------- ------- ------- ------- ------- ------- ------- --------- -------
  IVD Score            0.75     0.57     0.944                0.69    0.85    0.946       0.71     1.93    0.432   0.79    1.14    0.969   0.997   0.800   \>0.999   0.754
  ±0.71                ±0.450   ±0.530   ±0.71                ±0.57   ±2.23   ±0.906      ±1.52                                                                      
  Noto. Band/ NP (%)   23.77    49.24    **0.039**            16.05   50.53   **0.002**   16.47    19.39   0.905   17.17   22.38   0.633   0.893   0.999   0.998     0.898
  ±14.06               ±23.92   ±5.52    ±19.95               ±6.29   ±7.15   ±3.989      ±8.954                                                                     
  Cells/mm^2^          9977     2752     **\<0.001**          9275    4378    **0.001**   6952     5385    0.682   8633    5762    0.153   0.907   0.471   0.609     0.992
  ±2517                ±907     ±2230    ±2874                ±1390   ±2325   ±3538       ±2597                                                                      

10.1371/journal.pone.0227527.t004

###### IVD height index (DHI).

![](pone.0227527.t004){#pone.0227527.t004g}

                          Female   Male     CD versus WD (*p*)                                                                                                                       
  ----------------------- -------- -------- -------------------- -------- -------- ------------ -------- ------- ----------- ------- ------- ----------- ------- ------- ----------- ------------
  Vertebral length (mm)   2.965    2.848    0.563                3.079    2.729    **0.0003**   3.077    2.889   **0.007**   3.179   3.127   0.727       0.493   0.509   0.225       **0.0004**
  ±0.084                  ±0.143   ±0.155   ±0.214               ±0.085   ±0.117   ±0.134       ±0.081                                                                               
  IVD height (mm)         0.307    0.310    0.997                0.333    0.308    0.242        0.323    0.311   0.774       0.357   0.325   **0.037**   0.240   0.999   **0.030**   0.653
  ±0.031                  ±0.010   ±0.038   ±0.010               ±0.018   ±0.036   ±0.022       ±0.016                                                                               
  DHI                     0.103    0.109    0.768                0.108    0.116    0.359        0.105    0.108   0.863       0.112   0.104   0.068       0.819   0.603   0.146       0.688
  ±0.010                  ±0.007   ±0.009   ±0.013               ±0.006   ±0.010   ±0.007       ±0.004                                                                               

Motion segment torsional, but not axial, biomechanical behavior was compromised with leptin receptor deficiency {#sec014}
---------------------------------------------------------------------------------------------------------------

Leptin receptor deficiency significantly diminished torsional biomechanical properties of mice caudal motion segments ([Fig 8](#pone.0227527.g008){ref-type="fig"} and [Table 5](#pone.0227527.t005){ref-type="table"}). In Db/Db mice, cyclic torsional testing showed significantly decreased torsional stiffness and the torsion-to-failure test further demonstrated significantly decreased torsional failure strength with Db/Db genotype for both sexes. WD caused a small but significant increase in torsional failure strength in both sexes. The angle-to-failure, on the other hand, significantly decreased in female Db/Db mice only, while no changes were shown in male Db/Db mice. The majority of motion segments failed at the growth plate.

![Torsional strength decreased with Db/Db genotype.\
Schematic curves from A) axial-compression and torsion testing, B) Creep, and C) torsion to failure curves after biomechanical testing analysis. D) torsional stiffness E) Failure strength F) angle to failure. p\<0.05.](pone.0227527.g008){#pone.0227527.g008}

10.1371/journal.pone.0227527.t005

###### Biomechanical properties.

![](pone.0227527.t005){#pone.0227527.t005g}

                                                   Female    Male        CD versus WD (*p*)                                                                                                                              
  ------------------------ ----------------------- --------- ----------- -------------------- --------- ------------ --------- ------- ----------- -------- -------- ----------- -------- -------- ----------- --------- ---------
  Axial                    Compr.Stiff. (N/mm)     16.59     14.32       0.797                15.68     17.38        0.844     19.05   18.95       \>0.99   18.83    17.32       0.934    0.970    0.613       \>0.999   0.906
  ±4.98                    ±3.65                   ±3.09     ±3.68       ±5.08                ±3.81     ±7.42        ±4.54                                                                                               
  Tensile Stiff. (N/mm)    9.15                    12.1      0.705       11.61                13.31     0.858        12.81     12.06   0.976       11.92    11.84    \>0.99      0.719    0.965    0.967       0.999     
  ±3.89                    ±4.10                   ± 4.12    ±6.77       ±4.17                ±4.40     ±4.15        ±3.52                                                                                               
  ROM (mm)                 0.19                    0.19      \>0.99      0.17                 0.20      0.216        0.17      0.18    0.895       0.16     0.18     0.694       0.667    0.846    0.985       \>0.999   
  ±0.04                    ±0.03                   ±0.02     ±0.03       ±0.04                ±0.05     ±0.04        ±0.04                                                                                               
  Neutral Zone (mm)        0.07                    0.05      0.419       0.06                 0.07      0.525        0.06      0.07    0.543       0.06     0.07     0.974       0.787    0.254    0.956       0.984     
  ±0.03                    ±0.02                   ±0.02     ±0.02       ±0.02                ±0.03     ±0.02        ±0.02                                                                                               
  τ1 (fast resp.) (sec)    51.71                   54.75     0.992       41.85                37.68     0.965        45.13     41.79   0.975       32.51    53.220   0.086       0.683    0.392    0.449       0.487     
  ±27.13                   ±12.16                  ±13.84    ±16.55      ±9.83                ±21.00    ±14.78       ±20.41                                                                                              
  τ2 (slow resp.) (sec)    739.0                   900.8     0.570       707.7                669.0     0.982        724.7     746.2   0.989       453.1    806.0    **0.001**   0.990    0.268    **0.009**   0.821     
  ±255.8                   ±92.1                   ±242.7    ±194.4      ±182.8               ±134.8    ±37.8        ±171.8                                                                                              
  Creep Displ. (mm)        0.20                    0.21      0.972       0.18                 0.18      0.999        0.19      0.17    0.679       0.15     0.19     0.244       0.853    0.624    0.170       0.801     
  ±0.05                    ±0.02                   ±0.03     ±0.07       ±0.05                ±0.05     ±0.04        ±0.04                                                                                               
  Creep                    Total Displ. (mm)       0.24      0.25        0.982                0.22      0.22         0.994     0.23    0.20        0.598    0.18     0.23        0.257    0.882    0.635       0.186     0.718
  ±0.06                    ±0.03                   ±0.04     ±0.07       ±0.06                ±0.05     ±0.03        ±0.04                                                                                               
  Elastic Stiff. (N/mm)    11.66                   12.56     0.95        13.06                13.08     \>0.999      14.65     16.57   0.713       16.03    14.12    0.752       0.757    0.990    0.888       0.534     
  ±2.47                    ±2.39                   ±3.11     ±3.18       ±4.19                ±3.91     ±4.53        ±3.02                                                                                               
  Stiffness1 (N/mm)        12.64                   14.94     0.706       17.53                15.10     0.548        17.01     19.44   0.917       27.17    17.22    0.079       0.059    \>0.99   0.071       0.935     
  ±2.00                    ±2.73                   ±4.44     ±3.43       ±6.96                ±9.51     ±10.17       ±5.31                                                                                               
  Stiffness2 (N/mm)        3.15                    2.75      0.747       3.31                 3.12      0.943        3.27      3.73    0.664       4.08     2.99     0.078       0.965    0.810    0.243       0.294     
  ±0.94                    ±0.31                   ±0.50     ±0.79       ±0.93                ±0.93     ±0.97        ±0.89                                                                                               
  Torsion                  Tors. Stiff. (Nm/rad)   0.016     0.014       0.875                0.02      0.01         0.998     0.02    0.01        0.990    0.018    0.012       0.127    0.900    0.327       0.055     \>0.999
  ± 0.004                  ± 0.004                 ± 0.005   ± 0.005     ± 0.004              ± 0.005   ± 0.007      ± 0.006                                                                                             
  Failure Strength (Nm)    0.005                   0.003     0.073       0.007                0.004     **0.0002**   0.005     0.004   **0.025**   0.007    0.005    **0.005**   0.108    0.973    **0.042**   0.166     
  ± 0.002                  ± 0.001                 ± 0.001   ± 0.001     ± 0.001              ± 0.001   ± 0.001      ± 0.001                                                                                             
  Angle to Failure (rad)   1.013                   0.664     **0.038**   1.10                 0.69      **0.004**    0.87      1.05    \>0.99      0.889    1.185    0.812       0.852    0.997    0.695       0.213     
  ± 0.246                  ± 0.145                 ± 0.218   ± 0.201     ± 0.212              ± 0.332   ± 0.300      ± 0.421                                                                                             
  Torque Range (Nm)        0.003                   0.003     0.980       0.004                0.003     0.432        0.003     0.003   0.667       0.004    0.003    0.343       0.978    0.945    0.975       0.997     
  ±0.001                   ±0.001                  ±0.002    ±0.002      ±0.002               ±0.001    ±0.002       ±0.001                                                                                              
  Neutral Zone (rad)       0.39                    0.37      0.916       0.39                 0.40      0.946        0.34      0.38    0.414       0.36     0.39     0.675       \>0.99   0.652    0.962       \>0.999   
  ±0.04                    ±0.03                   ±0.04     ± 0.07      ± 0.06               ± 0.08    ±0.07        ±0.04                                                                                               

There were no significant differences between groups in axial biomechanical properties. Neither compressive and tensile stiffness, nor range of motion, or axial neutral zone length showed any significant changes associated with Db/Db genotype or WD ([Table 5](#pone.0227527.t005){ref-type="table"}). Additionally, there were no changes in creep parameters with Db/Db genotype or WD. No differences were observed in fast or slow time constants, creep displacements, or stiffnesses. Together, the highly significant changes in torsional biomechanical properties suggests leptin receptor deficiency and obesity had the largest functional changes in vertebral properties.

Discussion {#sec015}
==========

There is a need for a more mechanistic understanding of interactions between obesity, type 2 diabetes and spinal pathologies because of their increasing prevalence. This study used Db/Db mice with leptin receptor deficiency and Western diet to test the hypothesis that type 2 diabetes and obesity would develop dysfunctional vertebral structure, IVD morphology, and spinal biomechanical function in a sex-dependent manner. Db/Db mice and Western Diet both resulted in severe obesity, and Db/Db genotype also significantly increased HbA1c indicating diabetic/prediabetic conditions. The most important finding of our study is that the Db/Db genotype resulted in the severe alterations in spinal structures that were most prominent in females and subtle or not present in males. Specifically, Db/Db genotype increased vertebral trabecular bone volume fraction and density, decreased vertebral cortical thickness and area, disrupted IVD morphology, and resulted in increased motion segment torsional failure risk. Interestingly, Db/Db mice did not develop any signs of IVD degeneration and IVDs instead appeared less mature with large notochordal cells populating the NP, suggesting that diabetes and impaired leptin signaling had more substantial effects on vertebrae than on IVDs.

Clinically, obesity and type 2 diabetes are often associated with increased bone mineral density and fracture risk \[[@pone.0227527.ref050]--[@pone.0227527.ref052]\], which has been speculated to involve reduced cortical bone density in type 2 diabetics \[[@pone.0227527.ref053],[@pone.0227527.ref054]\]. In our study, no significant effects of diet were detected on trabecular bone properties, suggesting this was predominantly a diabetic- and not an obesity phenotype. In cortical bone, the Db/Db genotype caused increased bone volume to surface ratio, which is thought to reflect a more porous bone, potentially resulting in decreased strength \[[@pone.0227527.ref055]\]. In line with our study, Williams et al. found that lumbar vertebrae of 10 week-old male Db/Db mice had decreased cortical thickness but no changes in trabecular bone volume fraction. Huang et al. used lumbar vertebrae of 36 week old male mice and demonstrated that leptin receptor deficiency increased bone volume fraction and density and increased trabecular number \[[@pone.0227527.ref056]\], also consistent with our findings. Biomechanical testing of vertebra-IVD-vertebra motion segments demonstrated that the Db/Db genotype exhibited significantly reduced torsional failure strength for both sexes. In contrast, WD significantly increased failure strength on two-way ANOVA, leading us to conclude that the increased fracture risk involved the pre-diabetic/diabetic condition and not obesity. Torsional failure occurred in the growth plate, so that the inferior spinal torsional failure behaviors are suggestive of differences in growth or maturation patterns. However, inferior cortical bone changes in Db/Db genotype also resulted in significantly inferior cortical bone structure which could contribute to increased failure risk. Acevedo et al. demonstrated in diabetic rats that type 2 diabetes caused reduced whole-bone strength in vertebrae due to deficits in both structural and tissue material properties which resulted in diminished vertebral stiffness, lower yield force, and lower ultimate force of the lumbar vertebrae \[[@pone.0227527.ref057]\]. This study focused on structural biomechanical properties of motion segments in order to determine the functional behaviors and failure risk of these spinal segments. These results are limited since they do not distinguish material from structural properties or IVD from vertebral properties, which all contribute to motion segment biomechanical and failure behaviors \[[@pone.0227527.ref057],[@pone.0227527.ref058]\].

Leptin is likely to play a role in functional spinal behaviors. Similar to this db/db mouse model, UCD-T2DM diabetic rats developed defective leptin receptor signaling via beta cell decompensation \[[@pone.0227527.ref057]\]. Studies of children with congenital leptin deficiency suggest that leptin may mediate central control of bone mass. Leptin deficient children are obese but present normal age- and sex-related whole-body BMD \[[@pone.0227527.ref059]\], moreover, children with leptin receptor deficiency have a high bone mass phenotype \[[@pone.0227527.ref060]\]. While leptin dysfunction is only one aspect of diabetes, together with the literature, our data suggest that its dysfunction plays a significant role in diminished vertebral structure and material properties that can increase fracture risk, and might have important parallels with the clinical observations.

The association of metabolic syndrome with low back pain has greater prevalence in women than in men \[[@pone.0227527.ref061]\] and in our study, female Db/Db mice on WD had the most substantial effects on vertebral bone structure and IVDs. A limitation of this study is that we did not assess the underlying mechanisms that might be responsible for these observed sex-effects. Sex dependent effects of leptin receptor deficiency were also suggested in a recent study by McCabe et al. \[[@pone.0227527.ref062]\] who demonstrated that alterations of specific leptin receptor sites contributed to sex‐dependent bone responses to leptin, which could be particularly relevant during juvenile obesity, where loss of leptin signaling could diminish bone development and growth \[[@pone.0227527.ref062]\]. Sex hormones such as sex hormone-binding globulin have been identified to have sex-dependent effects on leptin and Type 2 diabetes \[[@pone.0227527.ref063],[@pone.0227527.ref064]\], and might explain the sex-dependent effects of leptin that were observed in this study. Future studies are required to address the effects of sex-hormones on leptin receptor deficiency mechanistically. We conclude that female mice had the most severe effects of Db/Db genotype and WD on spinal structures; although we note that female on WD had the most significant elevation of HbA1c levels, suggesting that their larger alterations in spinal structures may also be due to the greatest severity of the diabetic condition.

The lack of degenerative changes in IVDs of Db/Db mice is in contrast with our previous studies on western style diets in C57BL/6J mice, which demonstrated that pre-diabetes contributed to inferior vertebral quality, accelerated progression of IVD degeneration, and increased leptin levels \[[@pone.0227527.ref065]\]. The monogenic mutation of the Leptin receptor might not represent the clinical development of diabetes, however, the model provided important information about diminished leptin signaling in IVDs. Leptin is increased in degenerated human IVDs \[[@pone.0227527.ref033]\] and thought to stimulate cell proliferation of human NP cells via its receptors OBRa and OBRb \[[@pone.0227527.ref066]\]. Taking into account its contribution to IVD degeneration, diminished leptin signaling of our study might have been protective against IVD degeneration by maintaining large vacuolated cells in the notochordal band via decelerating NP cell proliferation and differentiation. Based on these observations, we speculate that leptin deficiency may have decelerated IVD degeneration despite the increased body weight and pre-diabetic status which likely caused IVD degeneration in prior animal models. Nevertheless, longer duration studies and aging may accumulate more IVD structural alterations suggestive of degeneration, as was observed in our type 1 diabetes model \[[@pone.0227527.ref027]\].

The present study applied Db/Db mice and WD in order to distinguish obesity effects from type 2 diabetes effects in adolescent mice. Highly processed Western diets cause excess calorie intake and are associated with the rising prevalence of obesity \[[@pone.0227527.ref067]\] and diabetes \[[@pone.0227527.ref067]\]. Our diet resembled a Western diet that is high in fat and low in carbohydrates and caused increased weight gain all groups; however, effects on spinal structures were overshadowed by the Db/Db genotype. While Db/Db genotype significantly increased HbA1c and blood glucose levels at some point during the study period, not all our Db/Db mice developed sustained hyperglycemia. Hyperglycemia in B6.BKS(D)-Leprdb/J is transient and does not manifest with stable elevated levels in all Db/Db mice \[[@pone.0227527.ref068]\]. To fully assess the diabetic status, we assessed HbA1c levels in addition to hyperglycemia, which revealed that most female Db/Db mice on WD did develop diabetes at some time during their lifespan and many mice in the Db/Db cohorts exhibited pre-diabetic conditions. The Db/Db model is well accepted in the literature as a type 2 diabetes model, although other diabetic models exist and assessments of spinal pathologies in additional diabetic mouse models and/or leptin impairments \[[@pone.0227527.ref069]\] would enable broadened interpretations. This model demonstrated that prediabetes/diabetes resulted in more substantial changes in spinal structures than obesity in these adolescent mice, although some effects of obesity were detected and longer duration diets in older mice are likely to result in more substantial spinal changes in support of the clinical literature that obesity can induce spinal changes in juveniles and adults \[[@pone.0227527.ref018],[@pone.0227527.ref070]\].

In conclusion, prediabetes/diabetes from leptin receptor deficiency resulted in cortical and trabecular bone changes and diminished torsional failure strength. Pre-diabetes/diabetes from leptin receptor deficiency dominated obesity effects and these changes were greatest in females. No evidence for IVD degeneration was observed, and taken with the literature, results suggested a potential protective role of impaired leptin signaling against diabetes‐ and obesity‐induced IVD degeneration.

Significance {#sec016}
------------

The tremendous public health burden of back pain is increasing, and is likely to grow due to known associations with obesity and DM, which are also increasing in prevalence. This study directly informs physiological factors important in spinal health, emphasizes the need to investigate sex differences, and highlights a potential role for leptin in the development and maturation of the spine.
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